✉ Email this page to a colleague
« Back to Dashboard
Soluprep is a drug marketed by 3m Health Care and is included in one NDA.
The generic ingredient in SOLUPREP is chlorhexidine gluconate; isopropyl alcohol. There are fifty-eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate; isopropyl alcohol profile page.
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for SOLUPREP
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for SOLUPREP
Identify potential brand extensions & 505(b)(2) entrants
|Fédération des médecins résidents du Québec||Phase 4|
|Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal||Phase 4|
|Claire Bourgeois||Phase 4|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|3m Health Care||SOLUPREP S||chlorhexidine gluconate; isopropyl alcohol||SOLUTION;TOPICAL||208288-001||Aug 8, 2018||OTC||Yes||Yes||⤷ Try a Trial||⤷ Try a Trial||⤷ Try a Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|